- Home
- ADXN vs LDWY Comparison
ADXN vs LDWY Comparison
Compare ADXN & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADXN | LDWY |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 6.2M |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | ADXN | LDWY |
|---|---|---|
| Price | $7.74 | $3.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.0K | ★ 55.1K |
| Earning Date | 12-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | $198,824.00 | ★ $69,769,000.00 |
| Revenue This Year | $86.57 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.83 |
| Revenue Growth | N/A | ★ 121.91 |
| 52 Week Low | $6.51 | $3.11 |
| 52 Week High | $12.05 | $6.19 |
Technical Indicators
Market Signals| Indicator | ADXN | LDWY |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 45.93 |
| Support Level | $7.66 | $3.32 |
| Resistance Level | $8.90 | $3.52 |
| Average True Range (ATR) | 0.43 | 0.27 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 38.62 | 22.32 |
Price Performance
Historical ComparisonAbout ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.